Zhejiang Orient Gene Biotech Co Ltd (688298): Gewinn- und Verlustrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 18,06 Renminbi Yuan | 28,99 Renminbi Yuan | 17,03 Renminbi Yuan |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 377,14 Renminbi Yuan | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 201.600.000 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
Umsatz | 958.994 | 827.916,211 | 820.157,331 | 8.767.938,105 | 10.169.167,714 | 3.265.355,637 | 367.376,82 | 285.892,847 | 224.237,368 | 182.255,119 |
Herstellungskosten | 560.899,414 | 659.259,399 | 640.513,745 | 5.157.685,036 | 2.681.996,247 | 753.244,322 | 194.866,744 | 149.009,026 | 118.109,604 | 95.536,77 |
Bruttoergebnis | 958.994 | 168.656,812 | 179.643,586 | 3.610.253,069 | 7.487.171,467 | 2.512.111,315 | 172.510,076 | 136.883,821 | 106.127,764 | 86.718,349 |
▸ Brutto-Marge | 100% | 20,37% | 21,9% | 41,18% | 73,63% | 76,93% | 46,96% | 47,88% | 47,33% | 47,58% |
Betriebliche Aufwendungen | 1.534.815,8 | 747.487,425 | 563.478,246 | 1.082.042,969 | 1.710.772,582 | 537.765,15 | 81.476,444 | 61.725,936 | 68.908,764 | 46.399,204 |
Operativer Gewinn/Verlust | -575.821,8 | -578.830,613 | -383.834,66 | 2.528.210,1 | 5.776.398,885 | 1.974.346,165 | 91.033,632 | 75.157,885 | 37.219 | 40.319,145 |
▸ Operative Marge | -60,04% | -69,91% | -46,8% | 28,83% | 56,8% | 60,46% | 24,78% | 26,29% | 16,6% | 22,12% |
Zinsen (Netto) | 70.442,8 | 172.421,851 | 188.412,922 | 108.063,925 | 32.481,511 | 3.762,664 | -2.387,736 | -4.011,884 | -11.860,013 | -7.757,846 |
▸ Zinsausgaben | 9.908,99 | 20.578,921 | 19.256,229 | 8.779,069 | 2.387,341 | 1.185,045 | 2.856,11 | 4.492,97 | 12.332,14 | 7.757,846 |
▸ Zinseinnahmen | 80.351,79 | 193.000,772 | 207.669,151 | 116.842,994 | 34.868,852 | 4.947,709 | 468,374 | 481,086 | 472,127 | - |
Andere Ausgaben | 71.691,9 | 178.902,061 | 208.804,99 | 165.521,658 | 38.914,827 | 3.827,369 | -2.651,124 | -5.853,674 | -14.459,18 | -11.234,242 |
Gewinn vor Steuern | -577.070,9 | -585.310,823 | -404.226,728 | 2.470.752,367 | 5.769.965,569 | 1.974.281,46 | 91.297,02 | 76.999,675 | 39.818,167 | 43.795,541 |
Steueraufwand | -13.451,9 | -16.488,361 | 14.042,1 | 373.321,128 | 829.319,798 | 293.950,244 | 13.789,457 | 13.043,671 | 7.112,428 | 8.168,519 |
Minderheitenanteil | - | -39.799,703 | -20.685,235 | 29.716,91 | 20.457,62 | 2.972,471 | -4.597,625 | -1.413,553 | - | - |
Nettogewinn/-verlust | -563.619 | -529.022,759 | -397.583,593 | 2.067.714,329 | 4.920.188,151 | 1.677.358,745 | 82.105,188 | 65.369,557 | 32.705,739 | 35.627,022 |
▸ Netto-Marge | -58,77% | -63,9% | -48,48% | 23,58% | 48,38% | 51,37% | 22,35% | 22,87% | 14,59% | 19,55% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.